Insulin receptor substrate 2 plays important roles in 17beta-estradiol-induced bone formation
- PMID: 19509476
- DOI: 10.1007/BF03345741
Insulin receptor substrate 2 plays important roles in 17beta-estradiol-induced bone formation
Abstract
Background: Discovering the mechanisms of the estrogen effects on the osteoblasts is very important for the development of new agents which have the clear-cut beneficial effects of estrogen while free of adverse effect.
Aim: The aim of this study was to investigate the differential gene expression of 17beta-estradiol (E2)-treated osteoblast-like cells, and the effect of E2 on the insulin receptor substrate 2 (IRS- 2) expression in human cultured osteoblast-like cells and the osteoblasts of ovariectomized (OVX) rats.
Material and methods: The differential gene expression of E2-treated osteoblast- like cells was analyzed by cytokine expression array and validated by RT-PCR and Western blot analysis. The protein expression and phosphorylation of one of the differentially expressed gene, IRS-2, treated at different times with E2 were analyzed. The Sprague-Dawley rats were ovariectomized and then treated with E2, the IRS-2 expression was analyzed by immunohistochemistry analysis.
Results: E2 upregulated the mRNA expression of IRS-2, bone morphogenetic protein 9, and connective tissue growth factor expression, down-regulated the mRNA expression of matrix metalloproteinase 15 and some tumor suppressor genes. Peak expression of IRS-2 was observed at 12-24 h of treatment by 10-8M E2. E2 can also increase the phosphorylation of IRS-2. The IRS-2 expression was down-regulated in the osteoblasts and bone marrow cells of the OVX rats, which had lower bone mineral density (BMD) than the normal rats. However, both BMD and IRS-2 expression can be rescued by 10-8M E2 in the OVX rats.
Conclusion: IRS-2 in osteoblast is up-regulated by E2 and plays important roles in the estrogen- induced bone formation.
Similar articles
-
An estrogen deficiency caused by ovariectomy increases plasma levels of systemic factors that stimulate proliferation and differentiation of osteoblasts in rats.Endocrinology. 1996 Feb;137(2):469-78. doi: 10.1210/endo.137.2.8593791. Endocrinology. 1996. PMID: 8593791
-
Estrogen modulates estrogen receptor alpha and beta expression, osteogenic activity, and apoptosis in mesenchymal stem cells (MSCs) of osteoporotic mice.J Cell Biochem Suppl. 2001;Suppl 36:144-55. doi: 10.1002/jcb.1096. J Cell Biochem Suppl. 2001. PMID: 11455579
-
Effects of 17β-estradiol on adiponectin regulation of the expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand.Bone. 2012 Sep;51(3):515-23. doi: 10.1016/j.bone.2012.05.011. Epub 2012 May 23. Bone. 2012. PMID: 22634178
-
Growth and characterization of N-methyl-N-nitrosourea-induced mammary tumors in intact and ovariectomized rats.Carcinogenesis. 2001 Dec;22(12):2039-47. doi: 10.1093/carcin/22.12.2039. Carcinogenesis. 2001. PMID: 11751437
-
Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis.J Bone Miner Res. 2002 Mar;17(3):394-405. doi: 10.1359/jbmr.2002.17.3.394. J Bone Miner Res. 2002. PMID: 11878304
Cited by
-
Insulin receptor substrate-1 time-dependently regulates bone formation by controlling collagen Iα2 expression via miR-342.FASEB J. 2016 Dec;30(12):4214-4226. doi: 10.1096/fj.201600445RR. Epub 2016 Sep 13. FASEB J. 2016. PMID: 27623927 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases